AC
EIGR

Annandale Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Annandale Capital’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,223
Closed -$26K – 143
2023
Q2 		$26K Hold
1,223
– – 0.01% 133
2023
Q1 		$33K Hold
1,223
– – 0.01% 130
2022
Q4 		$43K Buy
1,223
+223
+22% +$7.84K 0.01% 129
2022
Q3 		$226K Buy
+1,000
New +$226K 0.08% 111